Michael Partridge

Michael Partridge is a Senior Director at Regeneron since January 2022, having previously held the Director title in the same company. Partridge's experience at Regeneron Pharmaceuticals, Inc. spans over a decade, where roles included Senior Staff Scientist and Staff Scientist in Assay Development, focusing on developing and validating immunoassays for pharmacokinetics and immunogenicity studies. Prior experience includes work as a Scientist at Emisphere Technologies and an Associate Research Scientist at Columbia University, where research efforts concentrated on cancer linked to groundwater toxicity and the development of antibody assays for radiation exposure. Educational credentials include a BSc (Hons) in Biochemistry & Molecular Biology from UNSW and a Ph.D. in Immunoassays for Genetic Screening from the University of Sydney.